Chirfi Guindo
Executive Vice President, Strategic Access, Policy and Communications, Merck
In the news
Merck executives DeLuca and Guindo sell 21,050 shares at about $130-131 on August 6
SEC Form 4 filings show two Merck executives sold stock on August 6, 2026, days after the second-quarter report.
Insiders
Merck splits Human Health into Oncology and Specialty units and names new commercial leaders
Merck reorganized its Human Health business into an Oncology unit and a Specialty, Pharma and Infectious Diseases unit, and created a Strategic Access, Policy and Communications group.
Management